Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417024 · ClinicalTrials.gov registry record
Automated Breast Ultrasound Case Collection Registry
A clinical trial, sponsored by GE Healthcare.
- Terminated
- Registry status
- 13
- Enrollment target
NCT03417024 is a clinical trial that was terminated before completion, run by GE Healthcare. The registered enrollment target is 13 participants.
The verdict
NCT03417024 was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The contribution of automated breast ultrasound (ABUS) to the screening pathway for breast cancer is not fully understood. This prospective study aims to collect longitudinal data in women with dense breasts undergoing ABUS as a supplement to digital breast tomosynthesis (DBT). The data are intended for use in future research on the value and effectiveness of ABUS in routine clinical care. Data will be collected from eligible women who have been prescribed or have completed DBT and ABUS, screening within a 30-day window. Radiologist evaluations and, when performed, outcomes of biopsy and/or laboratory testing will be recorded. Subjects will be followed for breast cancer status and results of any diagnostic breast exams and/or treatment.
Interventions
- DEVICE Digital Breast Tomosynthesis
- DEVICE Automated Breast Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2019-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03417024
The ClinicalTrials.gov registry entry for NCT03417024 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Digital Breast Tomosynthesis is the first listed.
NCT03417024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03417024 about?
NCT03417024 is a clinical study titled "Automated Breast Ultrasound Case Collection Registry". The contribution of automated breast ultrasound (ABUS) to the screening pathway for breast cancer is not fully understood. This prospective study aims to collect longitudinal data in women with dense breasts undergoing ABUS as a supplement to digital breast tomosynthesis (DBT). The data are intended...
What is the current status of trial NCT03417024?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2018-07-12. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT03417024?
The interventions under investigation include: Digital Breast Tomosynthesis (DEVICE), Automated Breast Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03417024?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.